Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 151-175 of 1083 results.
{{ selectedCountPage }} items selected on this page,{{ selectedCountPage }} item selected on this page,{{ selectedCountTotal }} item in total{{ selectedCountTotal }} items in total
Study aim:
Comparison of the Effectiveness of Covid-19 specific antibody in hyperimmune bovine milk (...) outcomes of Covid-19 hospitalized patients
Design:
Double blind placebo control randomized clinical trial (...) . In that hospitalized patients of Covid- 19 diagnosis based on the random number table are divided in
with covid19 with olfactory disorders
Design:
A clinical trial with a control group, with parallel (...) study are over 18 years of age and a laboratory finding of covid19 infection, who mention olfactory (...) disorder in patients with covid19,
The effect of olfactory disorder on quality of life,
The effect of
of Covid19 in industrial workers
Design:
A randomized controlled trial with two parallel groups
Two (...)Covid-19 disease, whereas in the treatment group, the educational intervention is provided based on the (...) -efficacy
9- Preventive behaviors from Quid 19
-cov2(COVID-19)
Design:
Clinical trial with control group, with parallel, randomized groups, phase 2-3 (...) .
Settings and conduct:
At Amin Hospital in Isfahan, 80 patients with COVID-19 were selected and the (...) recorded for all patients prior to hospitalization. The diagnostic criterion for COVID-19 in patients to
criteria:
- patients with the clinical diagnosis or laboratory of covid-19, and have an indication for (...) oral medication
Intervention groups:
Intervention group: COVID-19 pneumonia receiving standard of care (...) Company/ three times a day
control group: COVID-19 pneumonia receiving standard of care as per Ministry
Study aim:
The effect of febuxostat on pulmonary complications of COVID-19
Design:
This is a double-blind, parallel-controlled clinical trial that will be conducted in two groups of 30 patients referred to coronavirus center.
Settings and conduct:
Patients with COVID-19, referred to the coronavirus
female and male patients affected by COVID-19 virus.
Design:
Before- after clinical trial study include of 24 female and 24 male COVID-19 patients, without randomization and blinding.
Settings and conduct:
Hospitalized patients in the Sina hospital who affected with COVID-19 with inclusion criteria will be enter to
Study aim:
Reducing in mortality and improve oxygenation in covid-19 patient's
Design:
covid-19patients admitted to the intensive care unit and who had severe respiratory failure and lack of adequate (...) criteria:
patient's admited in ICU and wards
Intervention groups:
covid-19patients admitted to the
Study aim:
The effect of Edaravone on the course of clinical signs in patients with COVID-19 will (...) with COVID-19 with mild to moderate pneumonia; 18 years to 80 Years; both genders. Exclusion criteria (...) .
Intervention groups:
will receive a standard regimen for COVID-19 plus Edaravone. Control group: will receive a
Study aim:
Investigating the effect of vitamin B1 on the symptoms of post covid-19 syndrome
Design (...) to enter the study (patients who have recovered from the disease of Covid-19, but their symptoms still persist more than usual, after three weeks of the onset of the symptoms of Covid-19, they also
hospitalization and mortality of patients with COVID virus 19 referred to the lung clinic
Design:
A randomized, controlled trial, based on outpatients with COVID-19, which has two parallel groups.
Settings and conduct:
COVID-19 patients with positive PCR or HRCT who refer to the lung clinic and are treated with methylene
Dibaj City Service Center. After the initial diagnosis of the covid-19 disease, according to the (...) diagnosis of covid-19 is made in the health service center and after the positive test, the patient is (...)
• Outpatients with Covid-19 symptoms after positive Covid-19 RT-PCR test
• Oxygen level 98-92%
Exclusion
in decreasing the symptoms of disease, hospitalization and mortality in COVID-19 outpatients who referred to pulmonary clinic
Design:
A randomized, controlled trial, based on outpatients with Covid-19, which has two parallel groups.
Settings and conduct:
Covid-19 patients with positive PCR or HRCT who
Study aim:
Evaluation the Efficacy of Sublingual Squalene for Treatment of COVID-19
Design:
Clinical trial with control group, with parallel groups, single-blind, cluster sampling, phase2 on 200 (...) .
Participants/Inclusion and exclusion criteria:
Inclusion criteria:
Molecularly confirmed COVID-19 disease or
exclusion criteria:
Inclusion criteria are adults over the age of 18 with a diagnosis of COVID-19 based on (...) clinical improvement of COVID-19 symptoms (...) Study aim:
Colchicine efficacy and safety on clinical symptoms improvement in patients with COVID
Study aim:
The effect of red blood cell exchange on hypoxemia in COVID-19 patients
Design:
A (...) patients with severe COVID-19, despite normal RBC counts, there is dysfunction in oxygen transfer due to (...) survival rate of patients with severe COVID-19 in Tehran.
Participants/Inclusion and exclusion criteria
Study aim:
To find the effectiveness of integrative treatment of COVID-19 patients.
Design (...) . Both genders
b. Aged between 18-80 years
c. Mild, moderate or severe infection.
d. COVID-19 positive (...) medicine parallel to PAK-20, Oniater and Hing for treatment of COVID-19.
e. Taking any
Covid19
Design:
The clinical trial has a control and intervention group that is collected in two (...) wards of patients in COVID-19.
Participants/Inclusion and exclusion criteria:
Inclusion criteria: Patients admitted to infectious wards due to Covid-19, without hearing, vision or speech impairment, non
Study aim:
Evaluation of the effects of Desferal on clinical symptoms in patients with COVID-19(...) of Medical Sciences, Bandar Abbas.The study population is 60 patients with COVID-19 (30 patients in (...) : Age >18 years, positive polymerase chain reaction (PCR) test for COVID-19, primary clinical symptoms
recovery of patients with COVID-19 in Hazrat Rasool Akram Hospitals: A Randomize Clinical Trial
Design (...) Rasool akram hospital, covid-19 admission wards
randomized clinical trial
Participants/Inclusion and exclusion criteria:
inclusion|:hospitalized patients with moderate to severe COVID-19 with stable vital
Covid-19 Anxiety Scale are completed by the participants before the intervention, at the end of the (...) , computer or laptop on the web, mild to moderate covid-19 anxiety level
Conditions of non-admission: history (...) -risk pregnancy, mothers with severe covid-19 anxiety, visual and hearing impairment,, migration in the
-19
Design:
Phases 3 randomized, parallel design clinical trial on 30 COVID-19 patients
Settings and (...) beheshti university of medical sciences on COVID-19 patients. in this study patients will receive anakinra (...) treatment to antiviral medication based on latest national protocol for treatment of COVID-19
Participants
clinical and laboratory symptoms in severe and resistant patients with COVID-19
Design:
This clinical (...)
Intervention groups:
In this study, the intervention is tofacitinib and the intervention group is severe COVID-19 patients.The control group is similar to the intervention group but they are not given tofacitinib
Study aim:
Study of the effect of ozonated autohemotherapy in patients with severe covid-19
Design (...) exclusion criteria:
Inclusion criteria: Severe cases of Covid-19 with chest CT changes in the form of (...) intervention group will receive the Iranian national protocol treatment of Covid-19 (which include any of the
patients with COVID-19
Design:
Controlled clinical trial with parallel group, open-label, phase 3, 60 (...) patients with COVID-19 (30 patients in control group and 30 in study group).
Participants/Inclusion and (...)COVID-19 or/and lung involvement in imaging, age ≥18 years, primary clinical symptoms, hospitalization